Gabapentin Tablet
NDC 71205-774
Product Information
Gabapentin is a ANDA-approved product labeled by Proficient Rx Lp. Gabapentin is used with other medications to prevent and control seizures. It is supplied as a white tablet for oral administration. This product entry covers the primary NDC 71205-774 and 3 associated package configurations. This profile includes active and inactive ingredient UNII references and FDA labeling data.
Primary Identification
Clinical Specifications
Labeler & Regulatory Data
Marketing Timeline
Product Characteristics
SG;178
Code Structure Chart
Product Details
What is NDC 71205-774?
What are the uses of this product?
What are Active Ingredients of this product?
- GABAPENTIN 800 mg/1 - A cyclohexane-gamma-aminobutyric acid derivative that is used for the treatment of PARTIAL SEIZURES; NEURALGIA; and RESTLESS LEGS SYNDROME.
Which are the associated UNII Codes?
The UNII codes for the active ingredients in this product are:
- GABAPENTIN (UNII: 6CW7F3G59X)
- GABAPENTIN (UNII: 6CW7F3G59X) (Active Moiety)
Which are the Inactive Ingredients associated UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- COPOVIDONE K25-31 (UNII: D9C330MD8B)
- TALC (UNII: 7SEV7J4R1U)
- HYPROMELLOSE, UNSPECIFIED (UNII: 3NXW29V3WO)
- CROSPOVIDONE (120 .MU.M) (UNII: 68401960MK)
- SILICON DIOXIDE (UNII: ETJ7Z6XBU4)
- TITANIUM DIOXIDE (UNII: 15FIX9V2JP)
- POLYETHYLENE GLYCOL, UNSPECIFIED (UNII: 3WJQ0SDW1A)
- POLOXAMER 407 (UNII: TUF2IVW3M2)
- MANNITOL (UNII: 3OWL53L36A)
- MAGNESIUM STEARATE (UNII: 70097M6I30)
- HYDROXYPROPYL CELLULOSE (1600000 WAMW) (UNII: RFW2ET671P)
What is the NDC to RxNorm Crosswalk for this product?
- RxCUI: 310434 - gabapentin 800 MG Oral Tablet
Which are the Pharmacologic Classes of this product?
* Please review the full disclaimer at the bottom of this page.